Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 183

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease

Open access
Karalliedde, Janaka, Gnudi, Luigi·2016·Nephrology Dialysis Transplantation

Abstract

Diabetes mellitus (DM) is increasingly recognized as a heterogeneous condition. The individualization of care and treatment necessitates an understanding of the individual patient's pathophysiology of DM that underpins their DM classification and clinical presentation. Classical type-2 diabetes mellitus is due to a combination of insulin resistance and an insulin secretory defect. Type-1 diabetes is characterized by a near-absolute deficiency of insulin secretion. More recently, advances in genetics and a better appreciation of the atypical features of DM has resulted in more categories of diabetes. In the context of kidney disease, patients with DM and microalbuminuria are more insulin resistant, and insulin resistance may be a pathway that results in accelerated progression of diabetic kidney disease. This review summarizes the updated classification of DM, including more rarer categories and their associated renal manifestations that need to be considered in patients who present with atypical features. The benefits and limitations of the tests utilized to make a diagnosis of DM are discussed. We also review the putative pathways and mechanisms by which insulin resistance drives the progression of diabetic kidney disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfu405

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 61

  1. Halban, 2014, Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment, J Clin Endocrinol Metab, 99, 1983, 10.1210/jc.2014-1425 · DOI · Paper page
  2. Atkinson, 2001, Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet, 358, 221, 10.1016/S0140-6736(01)05415-0 · DOI · Paper page
  3. Imkampe, 2011, Trends in type 1 diabetes incidence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991–2008, Diabet Med, 28, 811, 10.1111/j.1464-5491.2011.03288.x · DOI
  4. Solis-Herrera, 2014, Nephropathy in youth and young adults with type 2 diabetes, Curr Diab Rep, 14, 456, 10.1007/s11892-013-0456-y · DOI
  5. Dart, 2012, High burden of kidney disease in youth-onset type 2 diabetes, Diabetes Care, 35, 1265, 10.2337/dc11-2312 · DOI · Paper page
  6. Umpierrez, 2006, Ketosis-prone type 2 diabetes: time to revise the classification of diabetes, Diabetes Care, 29, 2755, 10.2337/dc06-1870 · DOI
  7. Thanabalasingham, 2011, Diagnosis and management of maturity onset diabetes of the young (MODY), BMJ, 343, d6044, 10.1136/bmj.d6044 · DOI · Paper page
  8. Steele, 2014, Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia, JAMA, 311, 279, 10.1001/jama.2013.283980 · DOI · Paper page
  9. Heidet, 2010, Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases, Clin J Am Soc Nephrol, 5, 1079, 10.2215/CJN.06810909 · DOI · Paper page
  10. Faguer, 2011, Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood, Kidney Int, 80, 768, 10.1038/ki.2011.225 · DOI · Paper page
  11. Jeha, 2005, Neonatal diabetes mellitus: patient reports and review of current knowledge and clinical practice, J Pediatr Endocrinol Metab, 18, 1095, 10.1515/JPEM.2005.18.11.1095 · doi:10.1515/jpem.2005.18.11.1095
  12. Naing, 2014, Maternally inherited diabetes and deafness (MIDD): diagnosis and management, J Diabetes Complications, 28, 542, 10.1016/j.jdiacomp.2014.03.006 · DOI
  13. Tuomi, 2014, The many faces of diabetes: a disease with increasing heterogeneity, Lancet, 383, 1084, 10.1016/S0140-6736(13)62219-9 · DOI · Paper page
  14. Adler, 2008, Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults, Diabetes Care, 31, 1789, 10.2337/dc08-0466 · DOI
  15. Adler, 2011, Hyperglycemia and death in cystic fibrosis-related diabetes, Diabetes Care, 34, 1577, 10.2337/dc10-2289 · DOI
  16. Creighton Mitchell, 2014, Diabetes and hemochromatosis, Curr Diab Rep, 14, 488, 10.1007/s11892-014-0488-y · DOI
  17. Farmer, 2012, Use of HbA1c in the diagnosis of diabetes, BMJ, 345, e7293, 10.1136/bmj.e7293 · DOI
  18. 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
  19. Genuth, 2006, Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes, Endocr Pract, 12, 34, 10.4158/EP.12.S1.34 · DOI
  20. 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  21. Yip, 1993, Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria, Lancet, 341, 369, 10.1016/0140-6736(93)90167-F · DOI
  22. Yip, 1993, Insulin resistance in insulin-dependent diabetic patients with microalbuminuria, Lancet, 342, 883, 10.1016/0140-6736(93)91943-G · DOI · Paper page
  23. Parvanova, 2006, Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion, Diabetes, 55, 1456, 10.2337/db05-1484 · DOI · Paper page
  24. Dwyer, 2012, Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND Study, Cardiorenal Med, 2, 1, 10.1159/000333249 · DOI
  25. MacIsaac, 2004, Nonalbuminuric renal insufficiency in type 2 diabetes, Diabetes Care, 27, 195, 10.2337/diacare.27.1.195 · DOI · Paper page
  26. Caramori, 2003, Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions, Diabetes, 52, 1036, 10.2337/diabetes.52.4.1036 · DOI · Paper page
  27. Lorenzo, 2008, Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria, Clin J Am Soc Nephrol, 3, 783, 10.2215/CJN.02730707 · DOI
  28. Sasson, 2012, Renal hyperfiltration related to diabetes mellitus and obesity in human disease, World J Diabetes, 3, 1, 10.4239/wjd.v3.i1.1 · DOI · Paper page
  29. Mogensen, 1986, Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy, Scand J Clin Lab Invest, 46, 201, 10.3109/00365518609083660 · DOI · Paper page
  30. Mogensen, 1971, Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus, Scand J Clin Lab Invest, 28, 91, 10.3109/00365517109090667 · doi:10.3109/00365517109090667
  31. Lurbe, 2002, Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes, N Engl J Med, 347, 797, 10.1056/NEJMoa013410 · DOI · Paper page
  32. Poulsen, 1994, Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients, Diabetes, 43, 1248, 10.2337/diab.43.10.1248 · DOI · Paper page
  33. Gnudi, 2007, Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism, J Am Soc Nephrol, 18, 2226, 10.1681/ASN.2006121362 · DOI
  34. De Vriese, 2001, Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide, Kidney Int, 60, 202, 10.1046/j.1523-1755.2001.00787.x · DOI
  35. Kagami, 1994, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells, J Clin Invest, 93, 2431, 10.1172/JCI117251 · DOI · Paper page
  36. Sharma, 2005, TGF-beta impairs renal autoregulation via generation of ROS, Am J Physiol Renal Physiol, 288, F1069, 10.1152/ajprenal.00345.2004 · DOI
  37. Anderson, 1995, Current concepts of renal hemodynamics in diabetes, J Diabetes Complications, 9, 304, 10.1016/1056-8727(95)80028-D · DOI
  38. Raij, 2005, The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease, Am J Hypertens, 18, 95S, 10.1016/j.amjhyper.2004.11.040 · DOI
  39. Maddox, 2000, Glomerular ultrafiltration, 319
  40. Arima, 2003, The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy, Nephrol Dial Transplant, 18, 1966, 10.1093/ndt/gfg263 · DOI
  41. Trevisan, 1998, Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria, Diabetes, 47, 1347
  42. Vedovato, 2004, Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance, Diabetologia, 47, 300, 10.1007/s00125-003-1303-5 · DOI
  43. Wilding, 2014, The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors, Metabolism, 63, 1228, 10.1016/j.metabol.2014.06.018 · DOI · Paper page
  44. Rahmoune, 2005, Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes, Diabetes, 54, 3427, 10.2337/diabetes.54.12.3427 · DOI · Paper page
  45. Cherney, 2014, Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus, Circulation, 129, 587, 10.1161/CIRCULATIONAHA.113.005081 · DOI · Paper page
  46. Shimabukuro, 2003, Hypoadiponectinemia is closely linked to endothelial dysfunction in man, J Clin Endocrinol Metab, 88, 3236, 10.1210/jc.2002-021883 · DOI · Paper page
  47. Deng, 2010, Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway, Int J Obes (Lond), 34, 165, 10.1038/ijo.2009.205 · DOI · Paper page
  48. Sharma, 2009, The link between obesity and albuminuria: adiponectin and podocyte dysfunction, Kidney Int, 76, 145, 10.1038/ki.2009.137 · DOI · Paper page
  49. Thorn, 2005, Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study), Diabetes Care, 28, 2019, 10.2337/diacare.28.8.2019 · DOI · Paper page
  50. Christou, 2014, The role of adiponectin in renal physiology and development of albuminuria, J Endocrinol, 221, R49, 10.1530/JOE-13-0578 · DOI
  51. Fischer, 2002, Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass, Acta Diabetol, 39, 105, 10.1007/s005920200027 · DOI · Paper page
  52. Hunley, 2010, Scope and mechanisms of obesity-related renal disease, Curr Opin Nephrol Hypertens, 19, 227, 10.1097/MNH.0b013e3283374c09 · DOI
  53. Wolf, 1999, Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments], Kidney Int, 56, 860, 10.1046/j.1523-1755.1999.00626.x · DOI · Paper page
  54. Otero, 2005, Leptin, from fat to inflammation: old questions and new insights, FEBS Lett, 579, 295, 10.1016/j.febslet.2004.11.024 · DOI · Paper page
  55. Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system?, Diabetologia, 41, 1241, 10.1007/s001250051058 · DOI · Paper page
  56. Wisse, 2004, The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity, J Am Soc Nephrol, 15, 2792, 10.1097/01.ASN.0000141966.69934.21 · DOI · Paper page
  57. Gnudi, 2012, Cellular and molecular mechanisms of diabetic glomerulopathy, Nephrol Dial Transplant, 27, 2642, 10.1093/ndt/gfs121 · DOI
  58. Welsh, 2010, Insulin signaling to the glomerular podocyte is critical for normal kidney function, Cell Metab, 12, 329, 10.1016/j.cmet.2010.08.015 · DOI · Paper page
  59. Coward, 2005, The human glomerular podocyte is a novel target for insulin action, Diabetes, 54, 3095, 10.2337/diabetes.54.11.3095 · DOI · Paper page
  60. Coward, 2007, Nephrin is critical for the action of insulin on human glomerular podocytes, Diabetes, 56, 1127, 10.2337/db06-0693 · DOI
  61. Fornoni, 2010, Proteinuria, the podocyte, and insulin resistance, N Engl J Med, 363, 2068, 10.1056/NEJMcibr1008395 · doi:10.1056/nejmcibr1008395

Cited by

See all 183

Metadata

Authors
Karalliedde, J., & Gnudi, L.
Venue
Nephrology Dialysis Transplantation
Published
2014-12-30
Volume
31
Issue
2
Pages
206-213
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2140437852
Cited by
183
References
9
FWCI
3.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/gfu405
The paper
Karalliedde, J., & Gnudi, L. (2016). Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfu405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.